Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1)
- PMID: 25517357
- DOI: 10.1001/jamadermatol.2014.3438
Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1)
Abstract
Importance: Familial chilblain lupus is a rare, autosomal dominant form of lupus erythematosus characterized by cold-induced inflammatory lesions at acral locations presenting in early childhood. Familial chilblain lupus is usually caused by a mutation in TREX1 (3' repair exonuclease 1).
Observations: We report on a family with dominant chilblain lupus segregating a novel TREX1 mutation (c.585C>G; H195Q) within the highly conserved exonuclease (Exo) III domain. Affected family members experienced cold-induced chilblain lesions of varying degrees, ranging from bluish-red infiltrations to mutilating necrotic ulcerations. In addition, all patients showed signs of systemic disease, such as arthritis, lymphopenia, or antinuclear antibodies. An increased expression of myxovirus resistance protein A in the skin and induction of interferon-stimulated genes in peripheral blood cells demonstrated activation of type I interferon.
Conclusions and relevance: This case further implicates type I interferon-dependent innate immune activation in the pathogenesis of TREX1-associated familial chilblain lupus. Unlike previously reported TREX1 mutations, which affect the Exo I or Exo II domains, the mutation presented here alters the Exo III domain, suggesting a particular role of mutations within the catalytic Exo domains in the pathogenesis of familial chilblain lupus. The high prevalence of extracutaneous manifestations, along with activation of type I interferon, underlines the systemic nature of familial chilblain lupus.
Similar articles
-
Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.JAMA Dermatol. 2019 Mar 1;155(3):342-346. doi: 10.1001/jamadermatol.2018.5077. JAMA Dermatol. 2019. PMID: 30673078 Free PMC article.
-
Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.Pediatr Rheumatol Online J. 2020 Apr 15;18(1):32. doi: 10.1186/s12969-020-00423-y. Pediatr Rheumatol Online J. 2020. PMID: 32293470 Free PMC article.
-
Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.Dermatology. 2009;219(2):162-6. doi: 10.1159/000222430. Epub 2009 May 28. Dermatology. 2009. PMID: 19478477
-
Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?Curr Rheumatol Rep. 2017 Aug 26;19(10):61. doi: 10.1007/s11926-017-0689-x. Curr Rheumatol Rep. 2017. PMID: 28844088 Review.
-
Human disease phenotypes associated with mutations in TREX1.J Clin Immunol. 2015 Apr;35(3):235-43. doi: 10.1007/s10875-015-0147-3. Epub 2015 Mar 4. J Clin Immunol. 2015. PMID: 25731743 Review.
Cited by
-
Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release.Nat Commun. 2024 Feb 20;15(1):1534. doi: 10.1038/s41467-024-45535-1. Nat Commun. 2024. PMID: 38378748 Free PMC article.
-
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases.Arch Pharm Res. 2023 Jun;46(6):500-534. doi: 10.1007/s12272-023-01452-3. Epub 2023 Jun 24. Arch Pharm Res. 2023. PMID: 37354378 Free PMC article. Review.
-
Identification and fine mapping of qPBR10-1, a novel locus controlling panicle blast resistance in Pigm-containing P/TGMS line.Mol Breed. 2021 Nov 30;41(12):75. doi: 10.1007/s11032-021-01268-3. eCollection 2021 Dec. Mol Breed. 2021. PMID: 37309514 Free PMC article.
-
Type I Interferonopathies in Childhood.Balkan Med J. 2023 May 8;40(3):165-174. doi: 10.4274/balkanmedj.galenos.2023.2023-4-78. Balkan Med J. 2023. PMID: 37161741 Free PMC article.
-
The Genetic Landscape of Cutaneous Lupus Erythematosus.Front Med (Lausanne). 2022 Jun 2;9:916011. doi: 10.3389/fmed.2022.916011. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35721085 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
